Safeguard Scientifics Common Top Management
SFEDelisted Stock | USD 0.46 0.19 29.23% |
Safeguard Scientifics employs about 26 people. The company is managed by 26 executives with a total tenure of roughly 178 years, averaging almost 6.0 years of service per executive, having 1.0 employees per reported executive. Evaluation of Safeguard Scientifics' management performance can provide insight into the firm performance.
Stephen Zarrilli CEO President CEO, Director |
Robert Rosenthal Chairman Executive Chairman of the Board, Principal Executive Officer |
Safeguard |
Safeguard Scientifics Management Team Effectiveness
The company has Return on Asset of (0.0778) % which means that on every $100 spent on assets, it lost $0.0778. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.2938) %, meaning that it generated no profit with money invested by stockholders. Safeguard Scientifics' management efficiency ratios could be used to measure how well Safeguard Scientifics manages its routine affairs as well as how well it operates its assets and liabilities.Safeguard Scientifics Workforce Comparison
Safeguard Scientifics Common is rated second in number of employees category among related companies. The total workforce of Financials industry is at this time estimated at about 3,969. Safeguard Scientifics maintains roughly 26.0 in number of employees contributing less than 1% to equities under Financials industry.
Safeguard Scientifics Notable Stakeholders
A Safeguard Scientifics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Safeguard Scientifics often face trade-offs trying to please all of them. Safeguard Scientifics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Safeguard Scientifics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mark Dow | CFO CEO | Profile | |
Stephen Zarrilli | President CEO, Director | Profile | |
Robert Rosenthal | Executive Chairman of the Board, Principal Executive Officer | Profile | |
Andrew Lietz | Independent Chairman of the Board | Profile | |
Mark Herndon | Chief Financial Officer, Senior Vice President | Profile | |
Scott Snyder | Senior Vice President Managing Director, Chief Technology and Innovation Officer | Profile | |
John Shave | Vice President - Business Development and Corporate Communications | Profile | |
Jeffrey McGroarty | CFO, Senior Vice President - Finance | Profile | |
Brian Sisko | Executive Vice President Managing Director | Profile | |
David Kille | CFO | Profile | |
Julie Dobson | Independent Director | Profile | |
Ira Lubert | Independent Director | Profile | |
Russell Glass | Independent Director | Profile | |
Maureen Morrison | Independent Director | Profile | |
George MacKenzie | Independent Director | Profile | |
Jack Messman | Independent Director | Profile | |
John Roberts | Independent Director | Profile | |
Stephen Fisher | Independent Director | Profile | |
Mara Aspinall | Director | Profile | |
Joseph Manko | Independent Director | Profile | |
Albert II | Sr. VP and Managing Director of Healthcare | Profile | |
Matthew Barnard | Secretary Counsel | Profile | |
Alex Fuiks | Associate | Profile | |
Eric Salzman | Chief Restructuring Officer | Profile | |
Mark CPA | VP CFO | Profile | |
Seth Zuckerman | Associate Healthcare | Profile |
About Safeguard Scientifics Management Performance
The success or failure of an entity such as Safeguard Scientifics often depends on how effective the management is. Safeguard Scientifics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Safeguard management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Safeguard management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. Safeguard Scientifics, Inc. is based in Radnor, Pennsylvania with additional office in Weston, Massachusetts. Safeguard Scientifics operates under Asset Management classification in the United States and is traded on NASDAQ Exchange.
The data published in Safeguard Scientifics' official financial statements usually reflect Safeguard Scientifics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Safeguard Scientifics. For example, before you start analyzing numbers published by Safeguard accountants, it's critical to develop an understanding of what Safeguard Scientifics' liquidity, profitability, and earnings quality are in the context of the Capital Markets space in which it operates.
Please note, the presentation of Safeguard Scientifics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Safeguard Scientifics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Safeguard Scientifics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Safeguard Scientifics Common. Please utilize our Beneish M Score to check the likelihood of Safeguard Scientifics' management manipulating its earnings.
Safeguard Scientifics Workforce Analysis
Traditionally, organizations such as Safeguard Scientifics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Safeguard Scientifics within its industry.Safeguard Scientifics Manpower Efficiency
Return on Safeguard Scientifics Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 395.7K | |
Net Loss Per Executive | 395.7K | |
Working Capital Per Employee | 754.1K | |
Working Capital Per Executive | 754.1K |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. Note that the Safeguard Scientifics information on this page should be used as a complementary analysis to other Safeguard Scientifics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Safeguard Stock
If you are still planning to invest in Safeguard Scientifics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Safeguard Scientifics' history and understand the potential risks before investing.
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
CEOs Directory Screen CEOs from public companies around the world | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Stocks Directory Find actively traded stocks across global markets |